You're reading the free version. Trader adds the live tape and alerts.
Start tracking
SNDX Sale Disclosure
Goldan Keith A. · SEC Form 4 · Filed Jun 2, 2026
Sale
Calculated transaction value
$22.35K
Goldan Keith A. Chief Financial Officer
SNDX
Transaction date
Jun 1, 2026
Public filing date
Jun 2, 2026
Filing lag
Filed 1 day later
SNDX daily price context
Close on/before transaction
$18.85
Jun 1, 2026
First close after public filing
$18.34
Jun 3, 2026
30-day return after filing
+18.97%
Through Jul 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,177 shares @ $18.99
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-253603
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$22.35K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Syndax Pharmaceuticals Inc SNDX Current | Sale | Jun 1, 2026 | $22.35K |